{"id":"https://openalex.org/W2906315467","doi":"https://doi.org/10.1183/13993003.congress-2018.pa688","title":"Late Breaking Abstract - Impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis)","display_name":"Late Breaking Abstract - Impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis)","publication_year":2018,"publication_date":"2018-09-15","ids":{"openalex":"https://openalex.org/W2906315467","doi":"https://doi.org/10.1183/13993003.congress-2018.pa688","mag":"2906315467"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2018.pa688","doi":"https://doi.org/10.1183/13993003.congress-2018.pa688","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2018.pa688","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Problems","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010278392","display_name":"Leonardo Michele Fabbri","orcid":"https://orcid.org/0000-0001-8894-1689","observed_orcids":["https://orcid.org/0000-0001-8894-1689"]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Leonardo Michele Fabbri","raw_affiliation_strings":["Sahlgrenska University Hospital, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sahlgrenska University Hospital, Gothenburg, Sweden","institution_ids":["https://openalex.org/I2801112325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028265360","display_name":"Klaus Friedrich Rabe","orcid":"https://orcid.org/0000-0002-7020-1401","observed_orcids":["https://orcid.org/0000-0002-7020-1401"]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]},{"id":"https://openalex.org/I4210129183","display_name":"German Center for Lung Research","ror":"https://ror.org/03dx11k66","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210129183","https://openalex.org/I4405256427"]},{"id":"https://openalex.org/I4210140903","display_name":"LungenClinic Grosshansdorf","ror":"https://ror.org/041wfjw90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210140903"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Klaus F. Rabe","raw_affiliation_strings":["LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Kiel, Germany","institution_ids":["https://openalex.org/I32021983","https://openalex.org/I4210129183","https://openalex.org/I4210140903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100767595","display_name":"Fernando J. Mart\u00ednez","orcid":"https://orcid.org/0000-0002-2412-3182","observed_orcids":["https://orcid.org/0000-0002-2412-3182","https://orcid.org/0000-0003-4957-8869","https://orcid.org/0000-0001-8298-2703"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fernando J. Martinez","raw_affiliation_strings":["Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, United States of America","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070315113","display_name":"Gary T. Ferguson","orcid":"https://orcid.org/0000-0002-3277-4110","observed_orcids":["https://orcid.org/0000-0002-3277-4110"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary T. Ferguson","raw_affiliation_strings":["Pulmonary Research Institute of Southeast Michigan, Farmington Hills, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Research Institute of Southeast Michigan, Farmington Hills, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100337500","display_name":"Chen Wang","orcid":"https://orcid.org/0000-0001-7857-5435","observed_orcids":["https://orcid.org/0000-0001-7857-5435","https://orcid.org/0000-0003-2638-3081"]},"institutions":[{"id":"https://openalex.org/I2801051648","display_name":"China-Japan Friendship Hospital","ror":"https://ror.org/037cjxp13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801051648"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chen Wang","raw_affiliation_strings":["National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China","institution_ids":["https://openalex.org/I2801051648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112637887","display_name":"Masakazu Ichinose","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]},{"id":"https://openalex.org/I4210093896","display_name":"Tohoku University Hospital","ror":"https://ror.org/00kcd6x60","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210093896"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masakazu Ichinose","raw_affiliation_strings":["Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan","institution_ids":["https://openalex.org/I201537933","https://openalex.org/I4210093896"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002972729","display_name":"Eric J. Bourne","orcid":"https://orcid.org/0000-0003-3915-320X","observed_orcids":["https://orcid.org/0000-0003-3915-320X"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Bourne","raw_affiliation_strings":["Pearl \u2013 A member of the AstraZeneca Group, Durham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl \u2013 A member of the AstraZeneca Group, Durham, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039653551","display_name":"Shaila Ballal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaila Ballal","raw_affiliation_strings":["Pearl \u2013 A member of the AstraZeneca Group, Morristown, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl \u2013 A member of the AstraZeneca Group, Morristown, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027975503","display_name":"Patrick F. Darken","orcid":"https://orcid.org/0000-0002-5608-2717","observed_orcids":["https://orcid.org/0000-0002-5608-2717"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Darken","raw_affiliation_strings":["Pearl \u2013 A member of the AstraZeneca Group, Morristown, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl \u2013 A member of the AstraZeneca Group, Morristown, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040582588","display_name":"Kiernan DeAngelis","orcid":"https://orcid.org/0000-0003-0807-6766","observed_orcids":["https://orcid.org/0000-0003-0807-6766"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kiernan Deangelis","raw_affiliation_strings":["Pearl \u2013 A member of the AstraZeneca Group, Durham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl \u2013 A member of the AstraZeneca Group, Durham, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081573795","display_name":"Magnus Aurivillius","orcid":"https://orcid.org/0000-0003-4660-5040","observed_orcids":["https://orcid.org/0000-0003-4660-5040"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Magnus Aurivillius","raw_affiliation_strings":["AstraZeneca Gothenburg, M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Gothenburg, M\u00f6lndal, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004903602","display_name":"Paul Dorinsky","orcid":"https://orcid.org/0000-0002-4814-0657","observed_orcids":["https://orcid.org/0000-0002-4814-0657"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Dorinsky","raw_affiliation_strings":["Pearl \u2013 A member of the AstraZeneca Group Gothenburg, Durham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl \u2013 A member of the AstraZeneca Group Gothenburg, Durham, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077419098","display_name":"Colin Reisner","orcid":"https://orcid.org/0000-0003-1856-9863","observed_orcids":["https://orcid.org/0000-0003-1856-9863"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colin Reisner","raw_affiliation_strings":["Pearl \u2013 A member of the AstraZeneca Group and AstraZeneca, Morristown, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl \u2013 A member of the AstraZeneca Group and AstraZeneca, Morristown, United States of America","institution_ids":["https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA688","last_page":"PA688"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eosinophil-count","display_name":"eosinophil count","score":0.8270000219345093},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.8769999742507935},{"id":"https://openalex.org/keywords/budesonide-glycopyrronium-formoterol","display_name":"budesonide/glycopyrronium/formoterol","score":0.9039999842643738},{"id":"https://openalex.org/keywords/metered-dose-inhaler","display_name":"MDI","score":0.8880000114440918},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.7440000176429749},{"id":"https://openalex.org/keywords/acute-exacerbation-of-copd","display_name":"COPD exacerbations","score":0.8029999732971191},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.8880000114440918},{"id":"https://openalex.org/keywords/laba-lama","display_name":"LAMA/LABA","score":0.843999981880188},{"id":"https://openalex.org/keywords/budesonide-formoterol","display_name":"budesonide/formoterol","score":0.9769999980926514},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C2780667556","wikidata":"https://www.wikidata.org/wiki/Q16897784","display_name":"Metered-dose inhaler","level":4,"score":0.7853929996490479},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7808893918991089},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.7328522205352783},{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.6903318166732788},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.597614049911499},{"id":"https://openalex.org/C2779871671","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol","level":4,"score":0.5743847489356995},{"id":"https://openalex.org/C3018587741","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung function","level":3,"score":0.4569573402404785},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.429423987865448},{"id":"https://openalex.org/C2777037409","wikidata":"https://www.wikidata.org/wiki/Q107238","display_name":"Eosinophil","level":3,"score":0.4251418113708496},{"id":"https://openalex.org/C2777419714","wikidata":"https://www.wikidata.org/wiki/Q1334805","display_name":"Dry-powder inhaler","level":4,"score":0.41464537382125854},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4073479175567627},{"id":"https://openalex.org/C2780261241","wikidata":"https://www.wikidata.org/wiki/Q1394363","display_name":"Inhaler","level":3,"score":0.3934507966041565},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.3708702325820923},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.24247005581855774},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2018.pa688","doi":"https://doi.org/10.1183/13993003.congress-2018.pa688","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2018.pa688","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Problems","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4310713300","https://openalex.org/W3182265784","https://openalex.org/W4401334042","https://openalex.org/W3176316741","https://openalex.org/W3194812710","https://openalex.org/W3014508330","https://openalex.org/W6939961880","https://openalex.org/W3020329335","https://openalex.org/W2905962528","https://openalex.org/W7161568749"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"assess":[2],"the":[3,103,122],"relationship":[4],"of":[5,35,138,147,160],"baseline":[6,51,82,161,180],"eosinophil":[7],"(EOS)":[8],"levels":[9,146],"with":[10,136,151,178,193],"treatment":[11,125],"responses":[12],"to":[13],"BGF":[14,95,109,128,152,169],"MDI":[15,21,28,96,99,110,116,129,132,153,156,170,173],"320/14.4/10":[16],"\u00b5g":[17,23,30],"(ICS/LAMA/LABA),":[18],"glycopyrronium/formoterol":[19],"[GFF]":[20],"14.4/10":[22],"(LAMA/LABA)":[24],"and":[25,38,57,60,88],"budesonide/formoterol":[26],"[BFF]":[27],"320/10":[29],"(ICS/LABA).":[31],"Methods:":[32],"Pre-specified":[33],"analysis":[34],"lung":[36],"function":[37,166],"exacerbation":[39,112],"endpoints":[40],"in":[41,73,79,83,117,121,176,187],"a":[42,65],"Phase":[43],"III,":[44],"double-blind,":[45],"parallel-group,":[46],"24-week":[47],"study":[48],"(NCT02497001)":[49],"by":[50,61,102],"blood":[52,144],"EOS":[53,63,119,145,162,181,189,195],"count":[54],"(<150":[55],"cells/mm3":[56,105],"\u2265150":[58,104],"cells/mm3)":[59],"modelling":[62],"as":[64],"continuous":[66,123],"variable.":[67],"Results:":[68],"Most":[69],"subjects":[70,177],"(87.8%)":[71],"were":[72,100,157,174,185],"GOLD":[74],"group":[75],"B.":[76],"Overall":[77],"improvements":[78,137],"change":[80],"from":[81],"morning":[84],"pre-dose":[85],"trough":[86],"FEV1":[87,89],"AUC0\u22124":[90],"over":[91],"24":[92],"weeks":[93],"for":[94,127,133,168],"vs":[97,114,130,154,171],"GFF":[98,115,131,172],"driven":[101],"subgroup":[106],"(Table).":[107],"However,":[108],"reduced":[111],"rate":[113],"both":[118,188],"subgroups;":[120],"analyses,":[124],"differences":[126],"exacerbations":[134],"increased":[135],"~15%":[139],"or":[140],"more":[141],"beginning":[142],"at":[143],"50\u2013100":[148],"cells/mm3.":[149],"Improvements":[150],"BFF":[155],"generally":[158],"independent":[159],"counts.":[163],"Conclusion:":[164],"Lung":[165],"benefits":[167,184],"greater":[175],"higher":[179,192],"levels.":[182,196],"Exacerbation":[183],"evident":[186],"subgroups":[190],"but":[191],"increasing":[194]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2019-01-01T00:00:00"}